öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

ÄÏ»ª´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÒüÎÀ¶«

±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27

µ¼Ê¦ÐÕÃû£ºÒüÎÀ¶«
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º914

ËùÊôԺУ£ºÄÏ»ª´óѧ
ËùÊôԺϵ£ºÒ©Ñ§ÓëÉúÎï¿ÆÑ§Ñ§Ôº¡¢Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º»ù´¡Ò½Ñ§¡¢ÉúÎïѧ


ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºwdy**@126.com
ͨѶµØÖ·£ººþÄÏÊ¡ºâÑôÊÐÄÏ»ª´óѧÐÄѪ¹Ü¼²²¡Ñо¿Ëù


¸öÈ˼òÊö :
(1) ÒüÎÀ¶«(4/6)£¬ÌÇÄò²¡ºÏ²¢¶¯ÂöÖàÑùÓ²»¯»ù´¡¼°ÐÂÒ©Ñо¿£¬ºþÄÏÊ¡¿Æ¼¼Ìü£¬ºþÄÏÊ¡×ÔÈ»¿ÆÑ§½±£¬ÈýµÈ½±£¬2015¡££¨ÙÜÃÀ»ª£¬Ð¤¹ú»ª£¬Íõ×Ú±££¬ÒüÎÀ¶«£¬ÕųÚ£¬ÀîÇÚ¿­£©(2) ÒüÎÀ¶«(3/6)£¬ÒÔABCAlΪ°Ðµã·ÀÖζ¯ÂöÖàÑùÓ²»¯·¢Éú·¢Õ¹£¬ºþÄÏÊ¡¿Æ¼¼Ìü£¬ºþÄÏÊ¡×ÔÈ»¿ÆÑ§½±£¬ÈýµÈ½±£¬2012¡££¨ÌƳ¯¿Ë£¬Áζ˷¼£¬ÒüÎÀ¶«£¬ÑîÓÀ×Ú£¬ÄªÖгÉ£¬Ò×¹â»Ô£©(3) ÒüÎÀ¶«(2/9)£¬Ò½ÓÃСÐÍÖí±ê×¼»¯¡¢Ó¦Óùؼü¼¼Êõ¼°ÖØÒªÌØÐÔÑо¿£¬ÖØÇìÊУ¬ÖØÇìÊпƼ¼½ø²½½±£¬¶þµÈ½±£¬2011¡££¨Îºãü£¬ÒüÎÀ¶«£¬É̺£ÌΣ¬ÍõÓ£¬Îâ¾ü£¬¸ðÁ¼Åô£¬ÁõÓ»ÆÕý¸ù£¬ÁõÇÚ£©(4) ÒüÎÀ¶«(2/6)£¬NO-1886µ÷½ÚÌÇ´úлºÍÖ¬´úлµÄ×÷Óü°»úÖÆ£¬ºþÄÏÊ¡¿Æ¼¼Ìü£¬ºþÄÏÊ¡×ÔÈ»¿ÆÑ§½±£¬ÈýµÈ½±£¬2005¡££¨Íõ×Ú±££¬ÒüÎÀ¶«£¬ÌƳ¯¿Ë£¬Ï¯ÊØÃñ£¬Ò×¹â»Ô£¬Áõ¼ɽ£©

¿ÆÑй¤×÷ :
1990.01¡ª1991.12£¬Òâ´óÀû¹ú¼ÒÑо¿Î¯Ô±»á£¬ÁÙ´²ÉúÀíѧÑо¿Ëù£¬²©Ê¿ºó1994.01¡ª1996.12£¬Òâ´óÀû±ÈÈø´óѧ£¬ÊµÑéÍâ¿ÆÑо¿Ëù£¬²©Ê¿ºó1996.01¡ª1997.12£¬ÃÀ¹úÄϼÓÖÝ´óѧ£¬¸Î²¡ÖÐÐÄ£¬²©Ê¿ºó2002.11¡ª2003.03£¬ÈÕ±¾µÂµº´óѧÑо¿ÉúÔº£¬–ÑðBѧÑо¿¿Æ£¬¿Í†T½ÌÊÚ2004.02¡ª2004.06£¬ÈÕ±¾µÂµº´óѧÑо¿ÉúÔº£¬–ÑðBѧÑо¿¿Æ£¬¿Í†T½ÌÊÚ1982.07¡ª1984.06£¬ºþÄÏÒ½´ó¸½¶þÒ½Ôº£¬ÄÚ¿Æ£¬Ò½Ê¦1984.07¡ª1987.08£¬ºâÑôҽѧԺ£¬ÉúÎﻯѧ½ÌÑÐÊÒ£¬Öú½Ì1987.09¡ª1993.08£¬ºâÑôҽѧԺ£¬ÐÄѪ¹ÜÑо¿Ëù£¬½²Ê¦1993.09¡ª2000.08£¬ºâÑôҽѧԺ£¬ÐÄѪ¹ÜÑо¿Ëù£¬¸±½ÌÊÚ2000.09¡ªÖÁ½ñ£¬ ÄÏ»ª´óѧ£¬ÐÄѪ¹ÜÑо¿Ëù£¬½ÌÊÚÆÚ ¿¯->Li L(#)£¬Xie W(#)£¬Zheng XL£¬Yin WD(*)£¬Tang CK(*).A novel peptide adropin in cardiovascular diseases£¬Clinica Chimica Acta£¬2016£¬453£º107-113¡£ÆÚ ¿¯->He Ping-Ping(#)£¬OuYang Xin-Ping(#)£¬Li Yuan(#)£¬Lv Yun-Cheng£¬Wang Zong-Bao£¬Yao Feng£¬Xie Wei£¬Tan Yu-Lin£¬Li Liang£¬Zhang Min£¬Lan Gang£¬Gong Duo£¬Cheng Hai-Peng£¬Zhong Hui-Juan£¬Liu Dan£¬Huang Chong£¬Li Zhao-Xia£¬Zheng Xi-Long£¬Yin Wei-Dong(*)£¬Tang Chao-Ke(*)£¬MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice.PLos One£¬2015£¬10£¨9£©£ºe**-e**¡£ÆÚ ¿¯->Qiao Y(#)£¬Guo D£¬Meng L£¬Liu Q£¬Liu X£¬Tang C£¬Yi G£¬Wang Z£¬Yin W£¬Tian G£¬Yuan Z(*)£¬Oxidized-low density lipoprotein accumulates cholesterol esters via the PKC¦Á-adipophilin-ACAT1 pathway in RAW264.7 cells.£¬Mol Med Rep.2015£¬12£¨3£©£º3599-3606ÆÚ ¿¯->Peng J(#)£¬Lv YC(#)£¬He PP(#)£¬Tang YY£¬Xie W£¬Liu XY£¬Li Y£¬Lan G£¬Zhang M£¬Zhang C£¬Shi JF£¬Zheng XL£¬ Yin WD(*)£¬Tang CK(*)£¬Betulinic acid downregulates expression of oxidative stress-induced lipoprotein lipase via the PKC/ERK/c-Fos pathway in RAW264.7 macrophages£¬Biochimie£¬2015£¬119£º192-203¡£ÆÚ ¿¯->Lan G(#) £¬Xie W(#)£¬Li L(#)£¬Zhang M£¬Liu D£¬Tan YL£¬Cheng HP£¬Gong D£¬Huang C£¬Zheng XL£¬Yin WD(*)£¬Tang CK(*)£¬MicroRNA-134 Actives lipoprotein lipase-mediated Lipid Accumulation and Inflammatory Response by Targeting Angiopoietin-Like 4 in THP-1 Macrophages£¬Biochemical and Biophysical Research Communications¡£ÆÚ ¿¯->Su Z(#)£¬Lian G(#)£¬Mawatari K£¬Tang P£¬He S£¬Shimohata T£¬Wu Y£¬Yin W(*)£¬Takahashi A(*)£¬Identification and Purification of the CPD Photolyase in Vibrio parahaemolyticus RIMD**.£¬Photochem Photobiol.2015£¬91£¨5£©£º1165-1172¡£ÆÚ ¿¯->She M(#)£¬Laudon M£¬Yin W(*). Melatonin receptors in diabetes: a potential new therapeutical target?£¬Eur J Pharmacol.£¬2014£¬774£º220-223¡£ÆÚ ¿¯->She M(#)£¬Hu X£¬Su Z£¬Zhang C£¬Yang S£¬Ding L£¬Laudon M£¬Yin W(*)£¬Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats.Eur J Pharmacol.2014£¬727£º60-65¡£ÆÚ ¿¯->She M(#)£¬Hou H£¬Wang Z£¬Zhang C£¬Laudon M£¬Yin W(*)£¬Melatonin rescues 3T3-L1 adipocytes from FFA-induced insulin resistance by inhibiting phosphorylation of IRS-1 on Ser307£¬Biochimie.2014£¬103£º126-130¡£ÆÚ ¿¯->Tian GP(#)£¬Tang YY(#)£¬He PP(#)£¬Lv YC£¬Ouyang XP£¬Zhao GJ£¬Tang SL£¬Wu JF£¬Wang JL£¬Peng J£¬Zhang M£¬Li Y£¬Cayabyab FS£¬Zheng XL£¬Zhang DW£¬ Yin WD(*)£¬Tang CK(*)£¬The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice£¬Biochem Biophys Res Commun£¬2014£¬443£¨2£©£º428-34¡£ÆÚ ¿¯->He PP(#)£¬Ouyang XP(#)£¬Tang YY(#)£¬Liao L£¬Wang ZB£¬Lv YC£¬Tian GP£¬Zhao GJ£¬Huang L£¬Yao F£¬Xie W£¬Tang YL£¬Chen WJ£¬Zhang M£¬Li Y£¬Wu JF£¬Peng J£¬Liu XY£¬Zheng XL£¬ Yin WD(*)£¬Tang CK(*)£¬MicroRNA-590 attenuateslipid accumulation and pro-inflammatory cytokine secretion by targeting lipoprotein lipase gene in human THP-1 macrophages£¬Biochimie£¬2014£¬106£º81-90¡£ÆÚ ¿¯->Li Y(#)£¬He PP(#)£¬Zhang DW£¬Zheng XL£¬Cayabyab FS£¬Yin WD(*)£¬Tang CK(*)£¬Lipoprotein lipase: from gene to atherosclerosis£¬Atherosclerosis£¬2014£¬237£¨2£©£º597-608¡£ÆÚ ¿¯->Cao ZH(#)£¬Yin WD(#)£¬Zheng QY£¬Feng SL£¬Xu GL(*)£¬Zhang KQ(*).Caspase-3 is involved in IFN-gamma- and TNF-alpha-mediated MIN6 cells apoptosis via NF-kappaB/Bcl-2 pathway£¬Cell Biochemistry and Biophysics£¬2013£¬67£¨3£©£º1239-48¡£ÆÚ ¿¯->Wang PP(#)£¬She MH(#)£¬He PP(#)£¬Chen WJ£¬Laudon M£¬Xu XX£¬Yin WD(*)£¬Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: role of ATGL and HSL£¬Biochimie£¬2013£¬95£¨8£©£º1650-1654.ÆÚ ¿¯->He P(#)£¬Ouyang X(#)£¬Zhou S(#)£¬Yin W£¬Tang C£¬Laudon M£¬Tian S (*)£¬A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease.Horm Behav.2013£¬64£¨1£©£º1-7¡£ÆÚ ¿¯->Tian GP(#)£¬Chen WJ(#)£¬He PP(#)£¬Tang SL£¬Zhao GJ£¬Lv YC£¬Ouyang XP£¬Yin K£¬Wang PP£¬Cheng H£¬Chen Y£¬Huang SL£¬Fu Y£¬Zhang DW£¬ Yin WD(*)£¬Tang CK(*)£¬MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion£¬Biochimie£¬2012£¬94£¨12£©£º2749-55¡£ÆÚ ¿¯->Wang ZB(#)£¬Zeng HC(#)£¬Wei HS£¬Yi GH£¬Yu J£¬Wang YT£¬Zhang YL£¬Yin WD(*)£¬NO-1886 ameliorates glycogen metabolism in insulin-resistant HepG2 cells by GSK-3beta signalling£¬Journal of Pharmacy and Pharmacology£¬2012£¬64£¨2£©£º293-301¡£ÆÚ ¿¯->Li Q(#)£¬Yin W(*)£¬Cai M£¬Liu Y£¬Hou H,£¬Shen Q£¬Zhang C£¬Xiao J£¬Hu X£¬Wu Q£¬Funaki M£¬Nakaya Y£¬NO-1886 suppresses diet-induced insulin resistance and cholesterol accumulation through STAT5-dependent upregulation of IGF1 and CYP7A1.J Endocrinol.£¬2011£¬204£¨1£©£º47-56¡£ÆÚ ¿¯->Liu Y(#)£¬Wang ZB(#)(*)£¬Yin WD£¬Li QK£¬Cai MB£¬Yu J£¬Li HG£¬Zhang C£¬Zu XH£¬Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs£¬Lipids in Health and Disease£¬2011£¬10£º117¡£ÆÚ ¿¯->Chen SG(#)£¬Xiao J(#)£¬Liu XH£¬Liu MM£¬Mo ZC£¬Yin K£¬Zhao GJ£¬Jiang J£¬Cui LB£¬Tan CZ£¬ Yin WD£¬TangCK(*)£¬Ibrolipim increases ABCA1/G1 expression by the LXRalpha signaling pathway in THP-1 macrophage-derived foam cells£¬Acta Pharmacologica Sinica£¬2010£¬31£¨10£©£º1343-1349¡£ÆÚ ¿¯->She M(#)£¬Deng X£¬Guo Z£¬Laudon M£¬Hu Z£¬Liao D£¬Hu X£¬Luo Y£¬Shen Q£¬Su Z£¬ Yin W(*)£¬NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats.£¬Pharmacol Res.2009£¬59£¨4£©£º248-253¡£ÆÚ ¿¯->Ma X(#)£¬Hu YW(#)£¬Mo ZC£¬Li XX£¬Liu XH£¬Xiao J£¬Yin WD£¬Liao DF£¬Tang CK(*)£¬NO-1886 up-regulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells.£¬Cardiovasc Drugs Ther.2009£¬23£¨3£©£º199-206¡£ÆÚ ¿¯->Su B£¬Yang YB£¬Tuo QH£¬Zhu BY£¬Lei XY£¬ Yin W£¬Liao DF(*)£¬Anti-apoptotic effects of probucol are associated with downregulation of Daxx expression in THP-1 macrophage.Cardiovasc Drugs Ther£¬2007£¬21£¨1£©£º37-45¡£ÆÚ ¿¯->Liu Y(#)£¬Wang Z(*)£¬Yin W£¬Li Q£¬Cai M£¬Zhang C£¬Xiao J£¬Hou H£¬Li H£¬Zu X£¬Severe insulin resistance and moderate glomerulosclerosis in a minipig model induced by high-fat/ high-sucrose/ high-cholesterol diet.Adiponectin decreases plasma glucose and improves insulin sensitivity in diabetic Swine.Exp Anim.£¬2007£¬56£¨1£©£º11-20¡£ÆÚ ¿¯->Cai M(#)£¬Yin W(*)£¬Li Q£¬Liao D(*)£¬Tsutsumi K£¬Hou H£¬Liu Y£¬Zhang C£¬Li J£¬Wang Z£¬Xiao J£¬Effects of NO-1886 on inflammation-associated cytokines in high-fat/high-sucrose/high-cholesterol diet-fed miniature pigs.£¬Eur J Pharmacol.2006£¬540£º139-146¡£ÆÚ ¿¯->Zhang C(#)£¬Yin W(*)£¬Liao D£¬Huang L£¬Tang C£¬Tsutsumi K£¬Wang Z£¬Liu Y£¬Li Q£¬Hou H£¬Cai M£¬Xiao J£¬NO-1886 upregulates ATP binding cassette transporter A1 and inhibits diet-induced atherosclerosis in Chinese Bama minipigs.£¬J Lipid Res.2006£¬47£¨9£©£º2055-2063¡£ÆÚ ¿¯->Xi S(#)£¬Yin W(*)£¬Wang Z£¬Kusunoki M£¬Lian X£¬Koike T£¬Fan J£¬Zhang Q£¬A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis£¬Int J Exp Pathol.2004£¬85£¨4£©£º223-231¡£ÆÚ ¿¯->Yin W(#)(*)£¬Liao D(#)£¬Wang Z(#)£¬Xi S£¬Tsutsumi K£¬Koike T£¬Fan J£¬Yi G£¬Zhang Q£¬Yuan Z£¬Tang K.NO-1886 inhibits size of adipocytes, suppresses plasma levels of tumor necrosis factor-alpha and free fatty acids, improves glucose metabolism in high-fat/high-sucrose-fed miniature pigs.£¬Pharmacol Res.2004£¬49£¨3£©£º199-206¡£ÆÚ ¿¯->Yin W(#)(*)£¬Tsutsumi K.Lipoprotein lipase activator NO-1886£¬Cardiovasc Drug Rev£¬2003£¬21£¨1£©£º133-142¡£ÆÚ ¿¯->Yin W(#)(*)£¬Yuan Z£¬Tsutsumi K£¬Xie Y£¬Zhang Q£¬Wang Z£¬Fu G£¬Long G£¬Yang Y.A lipoprotein lipase-promoting agent, NO-1886, improves glucose and lipid metabolism in high fat, high sucrose-fed New Zealand white rabbits.Int J Exp Diabesity Res£¬2003£¬4£¨1£©£º27-34¡£ÆÚ ¿¯->Yin W(#)(*)£¬Yuan Z£¬Wang Z£¬Yang B£¬Yang Y.A Diet High in Saturated Fat and Sucrose Alters Glucoregulation and Induces Aortic Fatty Streaks in New Zealand White Rabbits£¬Int J Exp Diabetes Res.£¬2002£¬3£¨3£©£º179-184¡£ÆÚ ¿¯->лΡ(#)£¬Àîö¦£¬ ÒüÎÀ¶«£¬ÌƳ¯¿Ë(*)£¬¸»º¬¸ÊÓÍÈýõ¥Ö¬µ°°×´úлÏà¹Ø»ùÒòÓë¹ÚÐIJ¡£¬ÉúÀí¿ÆÑ§½øÕ¹£¬2016£¬47£¨1£©£º33-37¡£ÆÚ ¿¯->Àîö¦(#)£¬Ð»Î¡(#)£¬½ªÖ¾Ê¤(*)£¬ ÒüÎÀ¶«(*)£¬ÌƳ¯¿Ë(*)£¬ÎÒ¹ú¶¯ÂöÖàÑùÓ²»¯»ù´¡Ñо¿½üÈýÄê½øÕ¹£¬Öйú¶¯ÂöÓ²»¯ÔÓÖ¾£¬2015£¬£¨11£©£º1182-1188¡£ÆÚ ¿¯->Åí¾ê(#)£¬ÒüÎÀ¶«(*)£¬ÌƳ¯¿Ë(*)£¬Ö¬µ°°×֬øµÄµ÷¿ØÓ빦Äܼ°ÆäÖ¶¯ÂöÖàÑùÓ²»¯»úÖÆµÄÑо¿Ð½øÕ¹£¬Öйú¶¯ÂöÓ²»¯ÔÓÖ¾£¬2014£¬£¨03£©£º309-314¡£ÆÚ ¿¯->Íõ×Ú±£(#)£¬ÒüÎÀ¶«(*)£¬Ö¬µ°°×֬ø»î»¯¼ÁNO-1886µÄÑо¿ÏÖ×´¼°Õ¹Íû£¬Ò½Ñ§Ñо¿ÔÓÖ¾£¬2014£¬£¨07£©£º12-15¡£ÆÚ ¿¯->ºÎƽƽ(#)£¬Å·ÑôÐÂÆ½(#)£¬ÌÆÑÞÑÞ£¬Àî½ð·ï£¬ ÒüÎÀ¶«(*)£¬ÌƳ¯¿Ë(*)£¬¸ÊÓÍÈýõ¥Ë®Æ½Éý¸ßÓ붯ÂöÖàÑùÓ²»¯ÐÔÐÄѪ¹Ü¼²²¡µÄ¹ØÏµµÄÑо¿Ð½øÕ¹£¬Öйú¶¯ÂöÓ²»¯ÔÓÖ¾£¬2013£¬£¨10£©£º951-954¡£ÆÚ ¿¯->²ÌÂü²¨(#)£¬À¾ü(#)£¬ºúÀö(#)£¬ºÎƽƽ£¬ÖÜîھ꣬ ÒüÎÀ¶«(*)£¬NO-1886¶Ô¸ßÖ¬/¸ßÌÇ/¸ßµ¨¹Ì´¼ËÇÑøµÄСÐÍÖí×éÖ¯ÖÐÖ×Áö»µËÀÒò×Ó¦ÁºÍ°×ϸ°û½éËØ1¦Âµ°°×±í´ïµÄÓ°Ï죬Öйú¶¯ÂöÓ²»¯ÔÓÖ¾£¬2011£¬£¨09£©£º741-746¡£ÆÚ ¿¯->ÁõÏèÓî(#)£¬ ÒüÎÀ¶«£¬ÌƳ¯¿Ë(*)£¬Ö¬µ°°×õ¥Ã¸ÓëÌÇÄò²¡Ð¡£¬ÉúÀí¿ÆÑ§½øÕ¹£¬2014£¬45£¨1£©£º16-20¡£ÆÚ ¿¯->Ìï¹úƽ(#)£¬³ÂÎå¾ü£¬ºÎƽƽ£¬ ÒüÎÀ¶«£¬ÌƳ¯¿Ë(*)£¬Ö¬µ°°×õ¥Ã¸Ñо¿½øÕ¹¼°¶Ô¶¯ÂöÖàÑùÓ²»¯µÄÓ°Ï죬ÉúÀí¿ÆÑ§½øÕ¹£¬2012£¬£¨05£©£º345-350¡£×¨Öø->Áζ˷¼£¬ÁúÊ¯Òø£¬ºúÑ×࣬Ìï¹úƽ£¬³ÂÁÙϪ£¬ÌƳ¯¿Ë£¬Ò×¹â»Ô£¬âÕÇÚ»Û£¬ËïÉÙÎÀ£¬ÑîÇí£¬Îä´ºÑ࣬Áõ¼ɽ£¬ÕÔÕ½Ö¥£¬½ªÖ¾Ê¤£¬Ô¬Öлª£¬ÄªÖгÉ£¬ÍõË«£¬ ÒüÎÀ¶«£¬Íõ×ô£¬Òü¿­£¬Î£µ±ºã£¬¹Ëºé·á£¬Ð»Ö¾ÖÒ£¬14Õ£ºÖ¬·¾Ã¸£¬µ¨¹Ì´¼ÄæÏòתÔË»ù´¡ÓëÁÙ´²,Áζ˷¼£¬ÌƳ¯¿Ë Ö÷±à, ¿ÆÑ§³ö°æÉç, pp 240-259, Öйú, 2009

½ÌÓý±³¾° :
1976.09¡ª1979.07£¬ºâÑôҽѧԺ£¬ ҽѧԺ£¬»ñҽѧѧʿѧλ¡£ 1979.09¡ª1982.07£¬°üͷҽѧԺ£¬ ÉúÎﻯѧ£¬»ñ˶ʿѧλ¡£1998.09¡ª2003.12£¬ÖÐÄÏ´óѧ£¬ ²¡ÀíѧÓ벡ÀíÉúÀíѧ£¬»ñҽѧ²©Ê¿Ñ§Î»¡£


Ïà¹Ø»°Ìâ/ҽѧԺ Ñо¿Ëù ÐÄѪ¹Ü »ù´¡ ²©Ê¿ºó

  • ÁìÏÞʱ´ó¶îÓÅ»Ýȯ,Ïí±¾Õ¾Õý°æöλÔÓéÀֵǼÈë¿ÚÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ!
    ´ó¶îÓÅ»Ýȯ
    ÓÅ»ÝȯÁìÈ¡ºó72СʱÄÚÓÐЧ£¬10ÍòÖÖ×îÐÂöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿¼Ö¤Ààµç×Ó´òÓ¡öλÔÓéÀÖ¹Ù·½appÏÂÔØÈÎÄãÑ¡¡£º­¸ÇÈ«¹ú500ÓàËùԺУöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿Î¡¢200¶àÖÖÖ°Òµ×ʸñöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¡¢1100¶àÖÖ¾­µä½Ì²Ä£¬²úÆ·ÀàÐͰüº¬µç×ÓÊé¡¢Ìâ¿â¡¢È«Ì×öλÔÓéÀÖ¹Ù·½appÏÂÔØÒÔ¼°ÊÓÆµ£¬ÎÞÂÛÄúÊÇöλÔÓéÀÖ¹Ù·½appÏÂÔØ¸´Ï°¡¢¿¼Ö¤Ë¢Ì⣬»¹ÊÇ¿¼Ç°³å´ÌµÈ£¬²»Í¬ÀàÐ͵IJúÆ·¿ÉÂú×ãÄúѧϰÉϵIJ»Í¬ÐèÇó¡£ ...
    öλÔÓéÀֵǼÈë¿ÚÏÂÔØÓÅ»Ýȯ ±¾Õ¾Ð¡±à FreeÒ¼°Û·ÖÑ§Ï°Íø 2022-09-19
  • Öйú¿ÆÑ§ÔºÉòÑô×Ô¶¯»¯Ñо¿ËùöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÁÖÑï
    µ¼Ê¦ÐÕÃû£ºÁÖÑïÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º720ËùÊôԺУ£ºÖйú¿ÆÑ§ÔºÉòÑô×Ô¶¯»¯Ñо¿ËùËùÊôԺϵ£ºÖ°³Æ£ºÑо¿Ô±µ¼Ê¦ÀàÐÍ£º²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º»úеµç×Ó¹¤³ÌÑо¿ÁìÓò£ºË®Ï»úÆ÷È˼¼ÊõÑо¿ºÍ¿ª·¢¡£Ñо¿ÁìÓò£ºË®Ï»úÆ÷È˼¼ÊõÑо¿ºÍ¿ª·¢¡£[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º**µç×ÓÓʼþ£ºliny@sia.cn¸öÈ˼òÊö:1988Äê±ÏÒµÓÚ´óÁ¬Àí ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • º£ÄÏҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÂÀ´«Öù
    µ¼Ê¦ÐÕÃû£ºÂÀ´«ÖùÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º640ËùÊôԺУ£ºº£ÄÏҽѧԺËùÊôԺϵ£ºÁÙ´²Ñ§Ôº¡¢¹ÜÀíѧԺְ³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¼±Õïҽѧ¡¢¹«¹²ÎÀÉúÓëÔ¤·ÀҽѧÑо¿ÁìÓò£º¼±Î£ÖØÖ¢Ò½Ñ§¡¢ÎÀÉúÓ¦¼±¹ÜÀíÑо¿ÁìÓò£º¼±Î£ÖØÖ¢Ò½Ñ§¡¢ÎÀÉúÓ¦¼±¹ÜÀí[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºluchuanzhu@emss.cnͨѶµØÖ·£ºº£ÄÏÊ¡º£ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • Öйú¿ÆÑ§ÔºÉòÑô×Ô¶¯»¯Ñо¿ËùöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-̸½ð¶«
    µ¼Ê¦ÐÕÃû£ºÌ¸½ð¶«ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º553ËùÊôԺУ£ºÖйú¿ÆÑ§ÔºÉòÑô×Ô¶¯»¯Ñо¿ËùËùÊôԺϵ£ºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£º²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º¿ØÖÆÀíÂÛÓë¿ØÖÆ¹¤³ÌÑо¿ÁìÓò£º»úÆ÷È˼¼Êõ£¬´«¸ÐÆ÷ÍøÂçÒÔ¼°Êý×ÖÒ½ÁÆ¡£Ñо¿ÁìÓò£º»úÆ÷È˼¼Êõ£¬´«¸ÐÆ÷ÍøÂçÒÔ¼°Êý×ÖÒ½ÁÆ¡£[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º(024)-**µç×ÓÓʼþ£ºtanjind ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÁÖÄÈ
    µ¼Ê¦ÐÕÃû£ºÁÖÄÈÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º551ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º¶ù¿ÆºôÎü¡¢ÃâÒßÐÔ¼²²¡¡£Ñо¿ÁìÓò£º¶ù¿ÆºôÎü¡¢ÃâÒßÐÔ¼²²¡¡£[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºlinna**@163.com¸öÈ˼òÊö:¹¤×÷¾­Àú£º1993Äê7ÔÂÖÁ2010Äê12Ô£¬ÔÚÓÒ½­Ãñ×åҽѧԺ¸½ÊôÒ½ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Íõ½à
    µ¼Ê¦ÐÕÃû£ºÍõ½àÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º525ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º1.ÉöСÇò¼²²¡»ù´¡ÓëÁÙ´²Ñо¿2.ѪҺ¾»»¯·½Ïò3.ÂýÐÔÉöÔಡ´ÓÊÂÒ½ÁÆ¡¢½Ìѧ¡¢¿ÆÑй¤×÷24Ä꣬...[Õ¹¿ª]Ñо¿ÁìÓò£º1.ÉöСÇò¼²²¡»ù´¡ÓëÁÙ´²Ñо¿2.ѪҺ¾»»¯·½Ïò3.ÂýÐÔÉöÔಡ´ÓÊÂÒ½ÁÆ¡¢½Ì ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • º£ÄÏҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÁÎСƽ
    µ¼Ê¦ÐÕÃû£ºÁÎСƽÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º474ËùÊôԺУ£ºº£ÄÏҽѧԺËùÊôԺϵ£ºÁÙ´²Ñ§ÔºÖ°³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉñ¾­²¡Ñ§Ñо¿ÁìÓò£ºÄÔѪ¹Ü²¡/Éñ¾­ÃâÒßÐÔ¼²²¡Ñо¿ÁìÓò£ºÄÔѪ¹Ü²¡/Éñ¾­ÃâÒßÐÔ¼²²¡[ÊÕÆð]ͨѶ·½Ê½:°ì¹«µç»°£º**µç×ÓÓʼþ£ºliaoxp@163.comͨѶµØÖ·£ºº£¿ÚÊÐѧԺ·3ºÅº£ÄÏҽѧԺ¸öÈ˼òÊö: ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Íõ¿¡Àû
    µ¼Ê¦ÐÕÃû£ºÍõ¿¡ÀûÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º432ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º±ÇÑʰ©¼°²»Ôв»ÓýµÄÒÅ´«·Ö×Ó±ê־ɸѡ¼°ÆäÕïÁƼÛÖµÆÀ¼ÛÑо¿ÁìÓò£º±ÇÑʰ©¼°²»Ôв»ÓýµÄÒÅ´«·Ö×Ó±ê־ɸѡ¼°ÆäÕïÁƼÛÖµÆÀ¼Û[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£º**@163.com¸öÈ˼òÊö:¹¤×÷¾­Àú£º200 ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Àî¿¡
    µ¼Ê¦ÐÕÃû£ºÀî¿¡ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º387ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º¿ÚÇ»ò¢Ã湦ÄÜÖØ½¨Ñо¿ÁìÓò£º¿ÚÇ»ò¢Ã湦ÄÜÖØ½¨[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºlijunmh@126.com¸öÈ˼òÊö:¹¤×÷¾­Àú£º2003Äê4ÔÂÖÁ2007Äê5Ô£¬ÈοÚÇ»¿ÆµÚÒ»¸±Ö÷ÈÎ2007Äê6ÔÂÖÁ½ñ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Íõ¾Óƽ
    µ¼Ê¦ÐÕÃû£ºÍõ¾ÓƽÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º386ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º1£®Ö×ÁöÔ´ÐÔÃâÒßÇòµ°°×GµÄ¹¦Äܼ°Æä»úÖÆÑо¿£»2£®ÌìÈ»ÃâÒßÐźÅͨ·µ÷¿Ø»úÖÆÑо¿Ñо¿ÁìÓò£º1£®Ö×ÁöÔ´ÐÔÃâÒßÇòµ°°×GµÄ¹¦Äܼ°Æä»úÖÆÑо¿£»2£®ÌìÈ»ÃâÒßÐźÅͨ·µ÷¿Ø»úÖÆÑо¿[ÊÕÆð]ͨѶ·½Ê½:µç×Ó ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Áõ¼Ñ
    µ¼Ê¦ÐÕÃû£ºÁõ¼ÑÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º376ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º1.¼¹Öù¼¹ËèËðÉË£»2.×éÖ¯¹¤³ÌÓëвÄÁÏÑо¿ÁìÓò£º1.¼¹Öù¼¹ËèËðÉË£»2.×éÖ¯¹¤³ÌÓëвÄÁÏ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£º**@qq.com¸öÈ˼òÊö:¹¤×÷¾­Àú£º2010Äê8ÔÂÖÁ2013Äê6Ô£¬ÄÏ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÀîÑ©±ó
    µ¼Ê¦ÐÕÃû£ºÀîÑ©±óÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º366ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£º1.ÄÔѪ¹Ü¼²²¡·¢²¡»úÀíÓëÁÙ´²2.ñ²ðï·¢²¡»úÀíÓëÁÙ´²´ÓÊÂÒ½ÁÆ¡¢½Ìѧ¡¢¿ÆÑй¤×÷25Ä꣬Éó¤ÓÚÉñ...[Õ¹¿ª]Ñо¿ÁìÓò£º1.ÄÔѪ¹Ü¼²²¡·¢²¡»úÀíÓëÁÙ´²2.ñ²ðï·¢²¡»úÀíÓëÁÙ´²´ÓÊÂÒ½ÁÆ¡¢½Ìѧ¡¢¿Æ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Àµ²ýÉú
    µ¼Ê¦ÐÕÃû£ºÀµ²ýÉúÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º360ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖÐÒ©»ù´¡ÀíÂÛÑо¿¡¢ÖÐÒ©ÅÚÖÆ¡¢Êý¾ÝÍÚ¾òµÈ¼ÆËã»úÐÅÏ¢¼¼ÊõÔÚÖÐÒ½Ò©ÁìÓòµÄÓ¦ÓÃÑо¿ÁìÓò£ºÖÐÒ©»ù´¡ÀíÂÛÑо¿¡¢ÖÐÒ©ÅÚÖÆ¡¢Êý¾ÝÍÚ¾òµÈ¼ÆËã»úÐÅÏ¢¼¼ÊõÔÚÖÐÒ½Ò©ÁìÓòµÄÓ¦ÓÃ[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£º**@q ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • º£ÄÏҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕźêÓñ
    µ¼Ê¦ÐÕÃû£ºÕźêÓñÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º355ËùÊôԺУ£ºº£ÄÏҽѧԺËùÊôԺϵ£º»¤ÀíѧԺְ³Æ£ºµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º»¤ÀíѧÑо¿ÁìÓò£ºÕý³£·ÖÃäÑо¿ÁìÓò£ºÕý³£·ÖÃä[ÊÕÆð]¸öÈ˼òÊö:ÕźêÓñ£¬Å®£¬1964£­10£­29³öÉú£¬É½¶«À³Î÷ÏØÈË¡£Öй²µ³Ô±¡£º£ÄÏҽѧԺ»¤ÀíѧԺ¸¾¶ù¿Æ»¤Àíѧ½ÌÑÐÊÒ¸±Ö÷ÈΣ¬¸±½ÌÊÚ£¬Öú²úöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¸ºÔðÈË¡£¿Æ ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÅ¿µ
    µ¼Ê¦ÐÕÃû£ºÕÅ¿µÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º333ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÖ×ÁöÃâÒߵĻù´¡ÓëÁÙ´²Ñо¿ÁìÓò£ºÖ×ÁöÃâÒߵĻù´¡ÓëÁÙ´²[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºzlk**@126.com¸öÈ˼òÊö:¹¤×÷¾­Àú£º1991Äê7ÔÂÖÁ1994Äê5Ô£ºÎàÖÝÊкì»áÒ½Ôº·ÅÁƿƹ¤×÷¡£199 ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
  • ÓÒ½­Ãñ×åҽѧԺöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÌÕÀö¾Õ
    µ¼Ê¦ÐÕÃû£ºÌÕÀö¾ÕÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º316ËùÊôԺУ£ºÓÒ½­Ãñ×åҽѧԺËùÊôԺϵ£ºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÑо¿ÁìÓò£ºÑªÒºÏµÍ³¡¢·çʪÃâÒßϵͳ»ù´¡ÓëÁÙ´²Ñо¿ÁìÓò£ºÑªÒºÏµÍ³¡¢·çʪÃâÒßϵͳ»ù´¡ÓëÁÙ´²[ÊÕÆð]ͨѶ·½Ê½:µç×ÓÓʼþ£ºbstaoliju@163.com¸öÈ˼òÊö:¹¤×÷¾­Àú£º1991Äê7ÔÂÖÁ1993Äê2Ô ...
    ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
öλÔÓéÀÖ(xinhui)¹Ù·½ÍøÕ¾_öλÔÓéÀÖappÏÂÔØÈë¿Ú